谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Lorigerlimab, a Bispecific PD-1×CTLA-4 DART Molecule in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (mcrpc): A Phase 1 Expansion (exp) Cohort.

Jason J. Luke,Manish Sharma,Sreenivasa R. Chandana,Iwona A. Lugowska,Cezary Szczylik,Jakub Zolnierek,Gregory Michael Cote,Charlene Mantia,Rafal Dziadziuszko,Rachel E. Sanborn,Denise Casey,Lori Long,Ashley Ward,Patrick Kaminker,Angela Joubert James,Tiziana Di Pucchio,Bozena Cybulska-Stopa

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 1|浏览53
关键词
Metastatic Prostate Cancer,PD-1 and PD-L1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要